| Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy (NCT01936883) | British Columbia Cancer Agency | 2014-01-01 |
| Improving Compliance With Medical Testing Guidelines (NCT02430948) | Beth Israel Medical Center | 2014-01-01 |
| CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer (NCT02037464) | Sunnybrook Health Sciences Centre | 2014-01-01 |
| A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility Study (NCT02640131) | University Health Network, Toronto | 2014-01-01 |
| Real-Time MV/kV Image Guided Radiation Therapy (NCT01260909) | Stanford University | 2014-01-01 |
| PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer (NCT02042053) | NYU Langone Health | 2014-01-01 |
| TAK-700 in Castration Resistant Prostate Cancer (NCT01658527) | European Organisation for Research and Treatment of Cancer - EORTC | 2014-01-01 |
| Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate Cancer (NCT02004223) | Royal North Shore Hospital | 2014-01-01 |
| Sulforadex in Healthy Human Males MAD (NCT02055716) | Evgen Pharma | 2014-01-01 |
| Prostate Screening Study Using MRI in BRCA Carriers (NCT01990521) | Toronto Sunnybrook Regional Cancer Centre | 2014-01-01 |
| Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors (NCT02014337) | Corcept Therapeutics | 2014-01-01 |
| Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer (NCT02853409) | Ipsen | 2014-01-01 |
| Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer (NCT02040610) | Provision Center for Proton Therapy | 2014-01-01 |
| The Effects of Pilates in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary Incontinence (NCT02645136) | Universidade Estadual de Londrina | 2014-01-01 |
| The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study (NCT02041559) | Yonsei University | 2014-01-01 |
| A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer (NCT02066961) | Astellas Pharma Global Development, Inc. | 2013-12-31 |
| Carbohydrate Restriction and Prostate Cancer Growth (NCT01763944) | Duke University | 2013-12-16 |
| Early Changes In Multiparametric MRI In Prostate Cancer (NCT01959542) | Dana-Farber Cancer Institute | 2013-12-01 |
| Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer (NCT02137746) | SOTIO a.s. | 2013-12-01 |
| Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men (NCT02033447) | University College London Hospitals | 2013-12-01 |
| Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer (NCT02079025) | Exact Imaging | 2013-12-01 |
| 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer (NCT01993160) | University Health Network, Toronto | 2013-12-01 |
| A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors (NCT02009449) | Eli Lilly and Company | 2013-11-15 |
| Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy (NCT01834001) | National Cancer Institute (NCI) | 2013-11-13 |
| Consensus Method to Evaluate the Conformity of Prescription of a Chemotherapy (NCT02882178) | Institut Bergonié | 2013-11-01 |
| SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN) (NCT01953055) | Sunnybrook Health Sciences Centre | 2013-11-01 |
| An Exercise Trial and Economic Analysis in Men With Prostate Cancer (NCT02046837) | University Health Network, Toronto | 2013-11-01 |
| Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer (NCT02238366) | Ipsen | 2013-11-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Strategies to Improve Bone Health in Men on ADT (NCT02043236) | University Health Network, Toronto | 2013-11-01 |
| Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide (NCT01946165) | M.D. Anderson Cancer Center | 2013-10-31 |
| Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer (NCT02003924) | Pfizer | 2013-10-31 |
| Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients (NCT01995513) | Pfizer | 2013-10-22 |
| A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer (NCT02225093) | Astellas Pharma Europe B.V. | 2013-10-02 |
| Focal Therapy for Localised Prostate Cancer Using Irreversible Electroporation (NCT01726894) | University College London Hospitals | 2013-10-01 |
| Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning (NCT01950871) | Advanced Medical Diagnostics s.a. | 2013-10-01 |
| Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer (NCT01983709) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-10-01 |
| An Open-label Extension Study of PSMA ADC 2301 in mCRPC (NCT02020135) | Progenics Pharmaceuticals, Inc. | 2013-10-01 |
| Feasibility Study Into Adjustment of the Radiation Beam to Account for Prostate Motion During Radiotherapy. (NCT02033343) | Royal North Shore Hospital | 2013-10-01 |
| Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer (NCT01940276) | Duke University | 2013-10-01 |
| Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer (NCT02139774) | UNC Lineberger Comprehensive Cancer Center | 2013-10-01 |
| Collection of Blood Specimens for Circulating Tumor Cell Analysis (NCT01943500) | Viatar LLC | 2013-09-30 |
| Evaluation of Diet and Exercise in Prostate Cancer Patients (NCT01960881) | AbbVie | 2013-09-19 |
| Tivozanib + Enzalutamide in Adv Prostate Cancer (NCT01885949) | Massachusetts General Hospital | 2013-09-03 |
| Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer (NCT02793882) | Sir Mortimer B. Davis - Jewish General Hospital | 2013-09-01 |
| Application of Megavoltage Imaging to Reduce Artifact After Seed Implants (NCT01810627) | William St Clair | 2013-09-01 |
| A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer (NCT01858688) | Dana-Farber Cancer Institute | 2013-09-01 |
| A Safety and Feasibility Study of Mitotane in Prostate Cancer (NCT02057237) | University Health Network, Toronto | 2013-09-01 |
| Fusion Targeted Biopsy of the Prostate (NCT02013414) | Emory University | 2013-09-01 |
| Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate Cancer (NCT03225235) | The Greater Poland Cancer Centre | 2013-08-26 |
| Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer (NCT02092948) | Jonsson Comprehensive Cancer Center | 2013-08-22 |
| A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer (NCT01964170) | Astellas Pharma Inc | 2013-08-13 |
| PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO) (NCT03776045) | University of East Anglia | 2013-08-12 |
| Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer (NCT01867333) | National Cancer Institute (NCI) | 2013-08-12 |
| Pentafecta Outcomes After Robot-assisted Laparoscopic Radical Prostatectomy (NCT03706508) | Hospital de Clinicas de Porto Alegre | 2013-08-09 |
| Effect of Sulforaphane on Prostate CAncer PrEvention (NCT01950143) | Quadram Institute Bioscience | 2013-08-01 |
| Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development (NCT02106416) | NYU Langone Health | 2013-08-01 |
| STHLM3 - Prostate Cancer Diagnostic Trial (NCT03639649) | Karolinska Institutet | 2013-08-01 |
| Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks (NCT01844999) | Dana-Farber Cancer Institute | 2013-08-01 |
| Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy (NCT01913197) | St. Luke's-Roosevelt Hospital Center | 2013-08-01 |
| Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans (NCT01790451) | Clinical Research Office of the Endourological Society | 2013-08-01 |
| The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study (NCT01842750) | The Christie NHS Foundation Trust | 2013-08-01 |
| Engagement of Patients With Advanced Cancer (NCT02966509) | Stanford University | 2013-08-01 |
| Robot-Assisted MRI-Guided Prostate Biopsy (NCT02080052) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-07-25 |
| Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer (NCT01875250) | National Cancer Institute (NCI) | 2013-07-22 |
| Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy (NCT01867710) | Janssen Pharmaceutica N.V., Belgium | 2013-07-16 |
| Assessing The Impact Of Incorporating Charlson Comorbidity Scores On Patient Anxiety And Satisfaction (NCT03950180) | Benaroya Research Institute | 2013-07-12 |
| Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer (NCT01804231) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2013-07-09 |
| Resistance Training and Protein Supplementation for Prostate Cancer Survivors (NCT01909440) | University of Southern California | 2013-07-08 |
| Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men (NCT02379559) | Georgetown University | 2013-07-01 |
| Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy (NCT01804712) | Christopher Kane | 2013-07-01 |
| Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists (NCT02034812) | GenomeDx Biosciences Corp | 2013-07-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Prostatectomy Adaptive Radiation Therapy (ART) (NCT02034955) | University Health Network, Toronto | 2013-07-01 |
| CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer (NCT02070952) | Riverside Community Hospital, California | 2013-07-01 |
| Improving Erectile Function and Quality of Life After Prostate Cancer Treatment (NCT01996852) | Case Comprehensive Cancer Center | 2013-07-01 |
| Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer (NCT01845792) | University of Colorado, Denver | 2013-07-01 |
| MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research (NCT02313623) | Yale University | 2013-07-01 |
| Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE) (NCT03383016) | CHU de Quebec-Universite Laval | 2013-06-20 |
| A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care (NCT02236637) | Janssen Pharmaceutica N.V., Belgium | 2013-06-14 |
| Application of DWI in Diagnosis of Prostate Cancer (NCT04962269) | Peking University Third Hospital | 2013-06-12 |
| SBRT in 4 Fractions for Prostate Cancer (NCT03873090) | Istituto Clinico Humanitas | 2013-06-12 |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies (NCT01794793) | RECORDATI GROUP | 2013-06-10 |
| A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer (NCT02085252) | Takeda | 2013-06-03 |
| Treatment Preference and Patient Centered Prostate Cancer Care (NCT02032550) | University of Pennsylvania | 2013-06-01 |
| The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife (NCT02145494) | Royal Marsden NHS Foundation Trust | 2013-06-01 |
| Hypofractionated Radiotherapy for Prostate Cancer (NCT02311049) | University Hospital, Ghent | 2013-06-01 |
| Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer (NCT01828476) | Rutgers, The State University of New Jersey | 2013-06-01 |
| MRI Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal Balloon (NCT01979848) | University of California, Irvine | 2013-06-01 |
| Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer (NCT01839994) | Maria Sklodowska-Curie National Research Institute of Oncology | 2013-06-01 |
| Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer (NCT02020291) | WntResearch AB | 2013-06-01 |
| Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer (NCT02313298) | National Cancer Centre, Singapore | 2013-06-01 |
| Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy (NCT01909388) | Alfonso Gomez-Iturriaga | 2013-06-01 |
| SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone (NCT02928432) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2013-06-01 |
| 2013 Annual National Digital Rectal Exam (DRE) Day Study (NCT01886547) | St. Luke's Medical Center, Philippines | 2013-06-01 |
| Medical and Economic Evaluation for Intermediate-risk Prostate Cancer (NCT02271659) | Hospices Civils de Lyon | 2013-06-01 |
| Transurethral Ultrasonic Imaging For Detection and Classification of Prostate Cancer (NCT02307552) | University of California, Irvine | 2013-06-01 |
| Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer (NCT01706458) | University of Wisconsin, Madison | 2013-05-20 |
| Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer (NCT01867424) | National Cancer Institute (NCI) | 2013-05-14 |
| NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis (NCT01816048) | University of Wisconsin, Madison | 2013-05-01 |